The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial (Q33408750)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial |
scientific article |
Statements
1 reference
The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial (English)
1 reference
Richard D Baird
1 reference
George Wilding
1 reference
Carlo Toniatti
1 reference
Khin Thway
1 reference
William R Schelman
1 reference
Victor Moreno
1 reference
Lucy Hylands
1 reference
Ruth Riisnaes
1 reference
Martin Forster
1 reference
Aurelius Omlin
1 reference
Nathan Kreischer
1 reference
Heidrun Gevensleben
1 reference
Linda Sun
1 reference
John Loughney
1 reference
Manash Chatterjee
1 reference
Christopher L Carpenter
1 reference
Robert Iannone
1 reference
Stan B Kaye
1 reference
Johann S de Bono
1 reference
Robert M Wenham
1 reference
1 reference
Identifiers
1 reference